MyFinsight
Home
Blog
About
Contact
Download
Download image
Net earnings
$6,524M
(-51.32%↓ Y/Y)
Amortization of intangible
assets
$1,682M
(-10.44%↓ Y/Y)
Depreciation
$1,434M
(7.01%↑ Y/Y)
Trade accounts
payable and other...
$954M
(167.98%↑ Y/Y)
Share-based compensation
$664M
(-1.34%↓ Y/Y)
Inventories
-$195M
(-436.21%↓ Y/Y)
Investing and financing
losses, net
-$65M
(86.51%↑ Y/Y)
Net cash from
operating activities
$9,566M
(11.78%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$71M
(173.96%↑ Y/Y)
Canceled cashflow
$1,952M
Net increase
(decrease) in cash and cash...
$906M
(25.83%↑ Y/Y)
Canceled cashflow
$8,731M
Prepaid expenses and
other assets
$1,295M
(62.69%↑ Y/Y)
Trade receivables
$652M
(-5.64%↓ Y/Y)
Income taxes
-$5M
(99.94%↑ Y/Y)
Proceeds from stock
options exercised
$396M
(50.00%↑ Y/Y)
Proceeds from issuance of
long-term debt and debt...
$5M
(-97.76%↓ Y/Y)
Other
-$18M
(-100.00%↓ Y/Y)
Proceeds from sales of
investment securities
$3M
(-89.29%↓ Y/Y)
Net cash from (used
in) financing...
-$6,309M
(-16.75%↓ Y/Y)
Net cash from (used
in) investing...
-$2,422M
(-3.59%↓ Y/Y)
Canceled cashflow
$401M
Canceled cashflow
$21M
Dividends paid
$4,116M
(7.30%↑ Y/Y)
Repayments of long-term
debt and debt with...
$1,504M
(127.88%↑ Y/Y)
Purchases of common shares
$893M
(-31.04%↓ Y/Y)
Acquisitions of property and
equipment
$2,171M
(-1.63%↓ Y/Y)
Purchases of investment
securities
$167M
(-1.18%↓ Y/Y)
Acquisitions of businesses
and technologies,...
$105M
Proceeds from issuance of
(repayments of) short-term...
-$115M
(-15.00%↓ Y/Y)
Other
-$82M
(-811.11%↓ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
Abbott_Laboratories_logo-svg
ABT
Abbott_Laboratories_logo-svg
ABT